For male pattern hair loss, blocking DHT is the closest thing to addressing the root cause, and two drugs do it: finasteride and dutasteride. They’re related but meaningfully different, and the differences matter when you and your doctor are choosing one.

Up front: both are prescription medications. Nothing here is medical advice or a substitute for a conversation with a doctor. This is a plain-English summary of the published evidence so that conversation is a better one.

How they differ mechanically

DHT is produced from testosterone by the enzyme 5-alpha-reductase, which comes in multiple types:

  • Finasteride inhibits mainly type II, which is dominant in hair follicles and the prostate. At the standard 1 mg/day hair loss dose, it lowers serum DHT by roughly 70%.
  • Dutasteride inhibits both type I and type II, with far stronger binding and a much longer half-life, measured in weeks rather than hours. At 0.5 mg/day it suppresses serum DHT by 90%+ and reaches DHT in scalp tissue more completely.

That residual scalp DHT on finasteride is the theoretical reason dutasteride can work when finasteride plateaus.

The head-to-head evidence

Network meta-analyses since, including work by Gupta et al., have consistently ranked dutasteride 0.5 mg above finasteride 1 mg for regrowth at 24 weeks.

Other relevant data points from the literature: multi-year Japanese and Korean studies, where dutasteride is formally approved for hair loss, show sustained benefit and a stable safety profile. Switch studies also report that a meaningful share of men who plateau on finasteride see renewed improvement after moving to dutasteride.

The honest caveats: most head-to-head trials are about 6 months, shorter than the multi-year finasteride literature, and finasteride’s long-term safety dataset is simply larger and older.

Side effects: the part everyone actually cares about

Both drugs carry the same category of possible side effects: decreased libido, erectile dysfunction, reduced ejaculate volume, and less commonly mood changes or gynecomastia. In controlled trials the rates are low single digits and often not dramatically different from placebo, but real-world reports vary and individual experience is what matters.

Points worth knowing when talking to a prescriber:

  • Dutasteride’s stronger DHT suppression doesn’t clearly translate into proportionally more side effects in trials. Reported rates are broadly similar.
  • Dutasteride’s long half-life means side effects, if they occur, take much longer to wash out after stopping: weeks to months versus days.
  • Persistent post-drug symptoms, sometimes called post-finasteride syndrome, are reported, debated in the literature, and rare. Dismissing them entirely and catastrophizing them are both mistakes.
  • Both drugs lower PSA, which matters for prostate cancer screening. Your doctor should know you take them.
  • Both are contraindicated in pregnancy. Women who are or may become pregnant should not handle broken tablets or capsules.

Topical versions: the middle path

Topical finasteride is the most interesting recent development. A 2021 randomized trial of topical finasteride spray found scalp benefit comparable to oral finasteride with markedly lower systemic drug exposure and less serum DHT suppression. The goal is the scalp effect with a smaller systemic footprint.

Compounded topical dutasteride and combination minoxidil + finasteride formulas are increasingly prescribed via dermatologists and telehealth services.

Two practical notes: topicals still absorb systemically, just less than oral versions, not zero. And combining prescription topicals with microneedling can multiply absorption. See the timing rules in the microneedling guide before stacking them.

So which one? A framework, not a prescription

The pattern in the literature and clinical practice looks like this:

  • Finasteride 1 mg is the standard starting point: approved for hair loss, best long-term dataset, and cheap as a generic.
  • Dutasteride is the escalation for men who plateau or keep progressing on finasteride, or occasionally a first choice for aggressive early loss. That is a doctor’s call.
  • Topical formulations may suit men who want DHT blockade with minimized systemic exposure.

Whichever direction, DHT blockers pair with, not replace, growth stimulation. The combination data for adding minoxidil and microneedling is the whole reason stacking is the standard of care. The full picture is in the complete protocol guide.

While the medications themselves require a prescription, the supporting stack doesn’t: 5% minoxidil, ketoconazole shampoo, and a dermastamp cover the over-the-counter half of the protocol.

This article is for informational purposes only and is not medical advice. Finasteride and dutasteride are prescription medications with real risks and benefits that should be weighed with a qualified healthcare provider.